The Asian Institute of Nephrology and Urology Private Limited ("AINU") has sold the majority stake by way of secondary sale and primary issuance of shares to Asia Healthcare Holdings Pte. Ltd. for an overall deal value of ₹600 crore.
Khaitan & Co advised AINU, the selling shareholders (including the promoters) and the exiting fund, HealthQuad Fund I in this transaction.
The core team consisted of Mayank Singh (Partner), Kevin Peter (Counsel), Kairavi Shah (Principal Associate), Esha Chauhan (Senior Associate), Hitakshi Mahendru (Senior Associate) with closing assistance from Mohnish Singh (Associate).
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.